Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
DocGo Inc. Market Cap
From what 0 stock analysts predict, the share price for DocGo Inc. (DCGO) might increase by 70.6% in the next year. This is based on a 12-month average estimation for DCGO. Price targets go from $5 to $8. The majority of stock analysts believe DCGO is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
DocGo Inc. has a total of 0 Wall St Analyst ratings. There are 0 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a sell consensus rating, the expectation is that DocGo Inc. will perform worse than the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of DCGO.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Sarah James Cantor Fitzgerald | Overweight | $5 | Reiterates | Aug 20, 2024 |
| Ryan MacDonald Needham | Buy | $7 | Reiterates | Aug 8, 2024 |
| David Larsen BTIG | Buy | $7 | Maintains | May 9, 2024 |
| Richard Close Canaccord Genuity | Buy | $5 | Maintains | May 9, 2024 |
| Sarah James Cantor Fitzgerald | Overweight | $5 | Maintains | May 9, 2024 |
| Ryan MacDonald Needham | Buy | $7 | Maintains | May 9, 2024 |
| David Grossman Stifel | Buy | $6.5 | Maintains | Apr 30, 2024 |
| Richard Close Canaccord Genuity | Buy | $9 | Maintains | Apr 11, 2024 |
| David Larsen BTIG | Buy | $11 | Maintains | Apr 10, 2024 |
| David Grossman Stifel | Buy | $8 | Maintains | Apr 10, 2024 |
| Sarah James Cantor Fitzgerald | Overweight | $11 | Maintains | Feb 29, 2024 |
| Ryan MacDonald Needham | Buy | $10 | Maintains | Feb 29, 2024 |
| Richard Close Canaccord Genuity | Buy | $10 | Maintains | Feb 29, 2024 |
| David Grossman Stifel | Buy | $11 | Maintains | Feb 23, 2024 |
| David Grossman Stifel | Buy | $12 | Reiterates | Nov 27, 2023 |
| Sarah James Cantor Fitzgerald | Overweight | $13 | Reiterates | Oct 2, 2023 |
| David Larsen BTIG | Buy | $13 | Maintains | Sep 19, 2023 |
| Ryan MacDonald Needham | Buy | $14 | Reiterates | Sep 18, 2023 |
| David Grossman Stifel | Buy | $12 | Reiterates | Sep 18, 2023 |
| Sarah James Cantor Fitzgerald | Overweight | $13 | Reiterates | Sep 14, 2023 |
When did it IPO
2020
Staff Count
2,915
Country
United States
Sector/Industry
Healthcare/Medical Care Facilities
CEO
Mr. Lee Bienstock
Market Cap
$369.9M
In 2023, DCGO generated $624.3M in revenue, which was a increase of 41.72% from the previous year. This can be seen as a signal that DCGO's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Wed, 21 Aug 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, announced today that management will be participating in the following investor conferences in August and September: Midwest Ideas Conference (August 28th – 29th) Norm Rosenberg, Chief Financial Officer will participate in 1x1 meetings, and deliver a presentation on Wednesday August 28th at 3:45PM. A webcast of the event will be available on the investor relations sec.
Wed, 07 Aug 2024
Sentiment - NEUTRAL
Source - Seeking Alpha
Summary - DocGo Inc. (NASDAQ:DCGO ) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Mike Cole – Vice President, Investor Relations Lee Bienstock - Chief Executive Officer Norman Rosenberg - Chief Financial Officer Conference Call Participants Sarah James - Cantor Fitzgerald Mike Latimore - Northland Capital Markets David Larsen – BTIG Pito Chickering - Deutsche Bank David Grossman - Stifel Ryan MacDonald - Needam Richard Close - Canaccord Genuity Operator Good day everyone, and welcome to the DocGo Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
Wed, 07 Aug 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights Total revenue for the second quarter of 2024 was $164.9 million, compared to $125.5 million in the second quarter of 2023, an increase of 31%. GAAP gross margin (which includes non-cash depreciation expenses) for the second qua.
Wed, 07 Aug 2024
Sentiment - NEGATIVE
Source - Zacks Investment Research
Summary - DocGo Inc. (DCGO) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.07 per share. This compares to loss of $0.02 per share a year ago.
Mon, 05 Aug 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced the launch of an innovative mobile x-ray program in partnership with MinXray. The program launched in New York City to provide rapid and accessible chest x-rays for vulnerable populations and help identify active Tuberculosis (“TB”) cases. With increasing TB cases in cities across the US, this program is a timely response to a growing.
Wed, 31 Jul 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced the launch of the Well Child Visits program in partnership with an insurance provider serving the New York City metropolitan area. Through DocGo's affiliated clinical practice group, this program will increase pediatric preventative care, strengthen childhood immunization rates and promote health equity by partnering with insurance pro.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
